Literature DB >> 12013199

Dermatomyositis in 132 patients with different clinical subtypes: cutaneous signs, constitutional symptoms and circulating antibodies.

A Parodi1, M Caproni, A V Marzano, C De Simone, M La Placa, P Quaglino, C Veller Fornasa, C Zane, M Vaccaro, M Papini, P Fabbri, A Rebora.   

Abstract

We retrospectively studied 132 patients with dermatomyositis; 84 had idiopathic, 30 paraneoplastic, 5 juvenile and 13 amyopathic forms of the disease. The commonest features were macular erythema, heliotropic erythema and Gottron's papules. Flagellate erythema occurred in 5% of patients with idiopathic dermatomyositis and correlated with the disease activity. Necrotic lesions were also found in this group of patients but did not always signal malignancy. The prevalence of malignancy was high (23%). Raynaud's phenomenon occurred in 10.6% of patients, also in those with malignancy. Dysphagia, interstitial lung disease and arthralgias affected 20%, 8% and 40% of patients, respectively. Anti-Jo-1 antibodies were found in 5% of patients with idiopathic dermatomyositis and low titre ANA in 1/3 of patients. ANA did not correlate with the disease activity. We confirmed the data from the literature, but no cutaneous sign, constitutional symptom or circulating antibody was found marking a particular subtype of the disease.

Entities:  

Mesh:

Year:  2002        PMID: 12013199     DOI: 10.1080/000155502753600894

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  10 in total

Review 1.  Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.

Authors:  Angela B Robinson; Ann M Reed
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

2.  Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo, Brazil.

Authors:  Luciena Cegatto Martins Ortigosa; Vitor Manuel Silva dos Reis
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

3.  Dysphagia in inflammatory myopathy: self-report, incidence, and prevalence.

Authors:  Kylie Patricia Mulcahy; Patricia Claire Langdon; Francis Mastaglia
Journal:  Dysphagia       Date:  2011-03-27       Impact factor: 3.438

4.  Pharyngeal dysphagia in inflammatory muscle diseases resulting from impaired suprahyoid musculature.

Authors:  P Claire Langdon; Kylie Mulcahy; Kelly L Shepherd; Vincent H Low; Frank L Mastaglia
Journal:  Dysphagia       Date:  2011-12-30       Impact factor: 3.438

5.  Dermatomyositis and cutaneous metastases from breast cancer: simultaneous development and parallel course.

Authors:  Mario Vaccaro; Francesco Borgia; Olga Barbuzza; Sebastiano Gangemi; Biagio Guarneri
Journal:  Rheumatol Int       Date:  2009-07-10       Impact factor: 2.631

6.  Evaluation of Swallowing Related Muscle Activity by Means of Concentric Ring Electrodes.

Authors:  J Garcia-Casado; G Prats-Boluda; Y Ye-Lin; S Restrepo-Agudelo; E Perez-Giraldo; A Orozco-Duque
Journal:  Sensors (Basel)       Date:  2020-09-15       Impact factor: 3.576

Review 7.  Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis.

Authors:  Rochelle L Castillo; Alisa N Femia
Journal:  Ann Transl Med       Date:  2021-03

8.  Lymphedema of the Arm after COVID-19 Vaccination in a Patient with Hidden Breast Cancer and Paraneoplastic Dermatomyositis.

Authors:  Cristina Aimo; Elena Biancamaria Mariotti; Alberto Corrà; Lavinia Quintarelli; Beatrice Bianchi; Alice Verdelli; Valentina Ruffo di Calabria; Marzia Caproni
Journal:  Vaccines (Basel)       Date:  2022-07-30

9.  Malignancy in dermatomyositis and polymyositis: analysis of 192 patients.

Authors:  Yao-Fan Fang; Yeong-Jian Jan Wu; Chang-Fu Kuo; Shue-Fen Luo; Kuang-Hui Yu
Journal:  Clin Rheumatol       Date:  2016-05-23       Impact factor: 3.650

10.  Trastuzumab-Associated Flagellate Erythema: Report in a Woman with Metastatic Breast Cancer and Review of Antineoplastic Therapy-Induced Flagellate Dermatoses.

Authors:  Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2015-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.